Terms: = Skin cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Clinical Outcome
11 results:
1. The emerging clinical relevance of genomic profiling in neuroendocrine tumours.
Burak GI; Ozge S; Cem M; Gulgun B; Zeynep DY; Atil B
BMC Cancer; 2021 Mar; 21(1):234. PubMed ID: 33676450
[TBL] [Abstract] [Full Text] [Related]
2. Correlation of histopathologic characteristics to protein expression and function in malignant melanoma.
Welinder C; Pawłowski K; Szasz AM; Yakovleva M; Sugihara Y; Malm J; Jönsson G; Ingvar C; Lundgren L; Baldetorp B; Olsson H; Rezeli M; Laurell T; Wieslander E; Marko-Varga G
PLoS One; 2017; 12(4):e0176167. PubMed ID: 28445515
[TBL] [Abstract] [Full Text] [Related]
3. Genomic microarray analysis on formalin-fixed paraffin-embedded material for uveal melanoma prognostication.
Minca EC; Tubbs RR; Portier BP; Wang Z; Lanigan C; Aronow ME; Triozzi PL; Singh A; Cook JR; Saunthararajah Y; Plesec TP; Schoenfield L; Cawich V; Sulpizio S; Schultz RA
Cancer Genet; 2014; 207(7-8):306-15. PubMed ID: 25442074
[TBL] [Abstract] [Full Text] [Related]
4. myc amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in-situ hybridization and immunohistochemical study.
Shon W; Sukov WR; Jenkins SM; Folpe AL
Mod Pathol; 2014 Apr; 27(4):509-15. PubMed ID: 24091875
[TBL] [Abstract] [Full Text] [Related]
5. PP2A-B56α controls oncogene-induced senescence in normal and tumor human melanocytic cells.
Mannava S; Omilian AR; Wawrzyniak JA; Fink EE; Zhuang D; Miecznikowski JC; Marshall JR; Soengas MS; Sears RC; Morrison CD; Nikiforov MA
Oncogene; 2012 Mar; 31(12):1484-92. PubMed ID: 21822300
[TBL] [Abstract] [Full Text] [Related]
6. Use of oncogene expression as an independent prognostic marker for primary melanoma.
Grover R; Pacifico MD; Wilson GD; Sanders R
Ann Plast Surg; 2003 Feb; 50(2):183-7. PubMed ID: 12567057
[TBL] [Abstract] [Full Text] [Related]
7. The c-myc oncogene: use of a biological prognostic marker as a potential target for gene therapy in melanoma.
Chana JS; Grover R; Tulley P; Lohrer H; Sanders R; Grobbelaar AO; Wilson GD
Br J Plast Surg; 2002 Dec; 55(8):623-7. PubMed ID: 12550114
[TBL] [Abstract] [Full Text] [Related]
8. Measurement of c-myc oncogene expression provides an accurate prognostic marker for acral lentiginous melanoma.
Grover R; Chana J; Grobbelaar AO; Hudson DA; Forder M; Wilson GD; Sanders R
Br J Plast Surg; 1999 Mar; 52(2):122-6. PubMed ID: 10434891
[TBL] [Abstract] [Full Text] [Related]
9. c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma.
Chana JS; Wilson GD; Cree IA; Alexander RA; Myatt N; Neale M; Foss AJ; Hungerford JL
Br J Ophthalmol; 1999 Jan; 83(1):110-4. PubMed ID: 10209447
[TBL] [Abstract] [Full Text] [Related]
10. Measurement of c-myc oncoprotein provides an independent prognostic marker for regional metastatic melanoma.
Grover R; Ross DA; Wilson GD; Sanders R
Br J Plast Surg; 1997 Oct; 50(7):478-82. PubMed ID: 9422944
[TBL] [Abstract] [Full Text] [Related]
11. Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma.
Mooy CM; Luyten GP; de Jong PT; Luider TM; Stijnen T; van de Ham F; van Vroonhoven CC; Bosman FT
Am J Pathol; 1995 Oct; 147(4):1097-104. PubMed ID: 7573354
[TBL] [Abstract] [Full Text] [Related]
